Vav synergizes with protein kinase CΘ to mediate IL-4 gene expression in response to CD28 costimulation in T cells

Journal of Immunology

Volumn 164, Issue 7, 2000, Pages 3829-3836

  Hehner, Steffen P ^a   Li Weber, Min ^a   Giaisi, Marco ^a   Dröge, Wulf ^a   Krammer, Peter H ^a   Schmitz, M Lienhard ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ENZYME VARIANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE; PROTEIN KINASE VAV; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME BINDING; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

EID: 0034176032     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.7.3829     Document Type: Article

References (70)

1. Hsieh, C. S., A. B. Heimberger, J. S. Gold, A. O'Garra, and K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89: 6065.
2. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
3. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
4. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
5. Mosmann, T. R., and R. L. Coffman. 1989. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46:111.
6. Lucey, D. R., M. Clerici, and G. M. Shearer. 1996. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin. Microbiol. Rev. 9:532.
7. Davydov, I. V., P. H. Krammer, and M. Li-Weber. 1995. Nuclear factor-IL6 activates the human IL-4 promoter in T cells. J. Immunol. 155:5273.
8. Lederer, J. A., V. L. Perez, L. DesRoches, S. M. Kim, A. K. Abbas, and A. H. Lichtman. 1996. Cytokine transcriptional events during helper T cell subset differentiation. J. Exp. Med. 184:397.
9. Kubo, M., J. Ransom, D. Webb, Y. Hashimoto, T. Tada, and T. Nakayama. 1997. T-cell subset-specific expression of the IL-4 gene is regulated by a silencer element and STAT6. EMBO J. 16:4007.
10. Li-Weber, M., M. Giaisi, and P. H. Krammer. 1998. Involvement of Jun and Rel proteins in up-regulation of interleukin-4 gene activity by the T cell accessory molecule CD28. J. Biol. Chem. 273:32460.
11. Li-Weber, M., P. Salgame, C. Hu, I. V. Davydov, O. Laur, S. Klevenz, and P. H. Krammer. 1998. Th2-specific protein/DNA interactions at the proximal nuclear faclor-AT site contribute to the functional activity of the human IL-4 promoter. J. Immunol. 161:1380.
12. Abe, E., R. De Waal Malefyt, I. Matsuda, K. Arai, and N. Arai. 1992. An II-base-pair DNA sequence motif apparently unique to the human interleukin 4 gene confers responsiveness to T-cell activation signals. Proc. Natl. Acad. Sci. USA 89:2864.
13. Li-Weber, M., H. Krafft, and P. H. Krammer. 1993. A novel enhancer element in the human IL-4 promoter is suppressed by a position-independent silencer. J. Immunol. 151:1371.
14. Bruhn, K. W., K. Nelms, J. L. Boulay, W. E. Paul, and M. J. Lenardo. 1993. Molecular dissection of the mouse interleukin-4 promoter. Proc. Natl. Acad. Sci. USA 90:9707.
15. Chuvpilo, S., C. Schomberg, R. Gerwig, A. Heinfling, R. Reeves, F. Grummt, and E. Serfling. 1993. Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res. 21:5694.
16. Szabo, S. J., J. S. Gold, T. L. Murphy, and K. M. Murphy. 1993. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc. Mol. Cell. Biol. 13:4793.
17. Todd, M. D., M. J. Grusby, J. A. Lederer, E. Lacy, A. H. Lichtman, and L. H. Glimcher. 1993. Transcription of the interleukin 4 gene is regulated by multiple promoter elements. J. Exp. Med. 177:1663.
18. Ho, I. C., M. R. Hodge, J. W. Rooney, and L. H. Glimcher. 1996. The protooncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85:973.
19. Zheng, W., and R. A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587.
20. Li, B., C. Tournier, R. J. Davis, and R. A. Flavell. 1999. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation EMBO J. 18:420.
21. Rooney, J. W., T. Hoey, and L. H. Glimcher. 1995. Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 5:473.
22. + cells. Eur. J. Immunol. 25:587.
23. Bretscher, P., and M. Cohn. 1970. A theory of self-nonself discrimination. Science 169:1042.
24. Su, B., E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben Neriah. 1994. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727.
25. Jung, S., A. Yaron, I. Alkalay, A. Hatzubai, A. Avraham, and Y. Ben Neriah. 1995. Costimulation requirement for AP-1 and NF-κB transcription factor activation in T cells. Ann. NY Acad. Sci. 766:245.
26. Lanzavecchia, A., G. Lezzi, and A. Viola. 1999. From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell 96:1.
27. Rudd, C. E. 1999. Adaptors and molecular scaffolds in immune cell signaling. Cell 96:5.
28. Cantrell, D. 1996. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:259.
29. Berridge, M. J. 1997. Lymphocyte activation in health and disease. Crit. Rev. Immunol. 17:155.
30. Werlen, G., E. Jacinto, Y. Xia, and M. Karin. 1998. Calcineurin preferentially synergizes with PKC-θ to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 17:3101.
31. Ghaffari Tabrizi, N., B. Bauer, A. Villunger, G. Baier Bitterlich, A. Altman, G. Utermann, F. Uberall, and G. Baier. 1999. Protein kinase Cθ, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells. Eur. J. Immunol. 29:132.
32. Cantrell, D. 1998. Lymphocyte signaling: a coordinating role for Vav? Curr. Biol. 8:R535.
33. Salojin, K. V., J. Zhang, and T. L. Delovitch. 1999. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway. J. Immunol. 163:844.
34. Crespo, P., K. E. Schuebel, A. A. Ostrom, J. S. Gutkind, and X. R. Bustelo. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385:169.
35. Han, J., K. Luby Phelps, B. Das, X. Shu, Y. Xia, R. D. Mosteller, U. M. Krishna, J. R. Falck, M. A. White, and D. Broek. 1998. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 279:558.
36. Wu, J., D. G. Motto, G. A. Koretzky, and A. Weiss. 1996. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 4:593.
37. Fang, N., and G. A. Koretzky. 1999. SLP-76 and Vav function in separate, but overlapping pathways to augment interleukin-2 promoter activity. J. Biol. Chem. 274:16206.
38. Schmitz, M. L., A. Indorf, F. P. Limbourg, H. Stadtler, E. B. Traenckner, and P. A. Baeuerle. 1996. The dual effect of adenovirus type 5 E1A 13S protein on NF-κB activation is antagonized by E1B 19K. Mol. Cell. Biol. 16:4052.
39. Shapiro, V. S., K. E. Truitt, J. B. Imboden, and A. Weiss. 1997. CD28 mediates transcriptional up-regulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol. 17:4051.
40. Hoben, O., J. W. Schilling, M. C. Beckerle, A. Ullrich, and B. Jallal. 1996. SH3 domain-dependent interaction of the proto-oncogene product Vav with the focal contact protein zyxin. Oncogene 12:1577.
41. Musci, M. A., D. G. Motto, S. E. Ross, N. Fang, and G. A. Koretzky. 1997. Three domains of SLP-76 are required for its optimal function in a T cell line. J. Immunol 159:1639.
42. Zhang, W., C. L. Sommers, D. N. Burshtyn, C. C. Stebbins, J. B. DeJarnette, R. P. Trible, A. Grinberg, H. C. Tsay, H. M. Jacobs, C. M. Kessler, et al. 1999. Essential role of LAT in T cell development. Immunity 10:323
43. Moriguchi, T., F. Toyoshima, N. Masuyama, H. Hanafusa, Y. Gotoh, and E. Nishida. 1997. A novel SAPK/JNK kinase, MKK7, stimulated by TNFα and cellular stresses. EMBO J. 16:7045.
44. Leung, I. W., and N. Lassam. 1998. Dimerization via tandem leucine zippers is essential for the activation of the mitogen-activated protein kinase kinase kinase, MLK-3. J. Biol. Chem. 273:32408.
45. Woronicz, J. D., X. Gao, Z. Cao, M. Rothe, and D. V. Goeddel. 1997. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278:866.
46. Costello, P. S., A. E. Walters, P. J. Mee, M. Turner, L. F. Reynolds, A. Frisco, N. Sarner, R. Zamoyska, and V. L. Tybulewicz. 1999. The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-κB pathways. Proc. Natl. Acad. Sci. USA 96:3035.
47. Baier, G., D. Telford, L. Giampa, K. M. Coggeshall, G. Baier Bitterlich, N. Isakov, and A. Altman. 1993. Molecular cloning and characterization of PKC θ, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J. Biol. Chem. 268:4997.
48. Monks, C. R., H. Kupfer, I. Tamir, A. Barlow, and A. Kupfer. 1997. Selective modulation of protein kinase C-θ during T-cell activation. Nature 385:83.
49. Kong, Y. Y., K. D. Fischer, M. F. Bachmann, S. Mariathasan, I. Kozieradzki, M. P. Nghiem, D. Bouchard, A. Bernstein, P. S. Ohashi, and J. M. Penninger. 1998. Vav regulates peptide-specific apoptosis in thymocytes. J. Exp. Med. 188: 2099.
50. Beraud, C., W. J. Henzel, and P. A. Baeuerle. 1999. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation. Proc. Natl. Acad. Sci. USA 96:429.
51. Bender, K., M Gottlicher, S. Whiteside, H. J. Rahmsdorf, and P. Herrlich. 1998. Sequential DNA damage-independent and -dependent activation of NF-κB by UV. EMBO J. 17:5170.
52. Li, N., and M. Karin. 1998. Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA 95:13012.
53. Paliogianni, F., N. Kama, G. J. Mavrothalassitis, G. Thyphronitis, and D. T. Boumpas. 1996. Signal requirements for interleukin 4 promoter activation in human T cells. Cell. Immunol. 168:33.
54. Clipstone, N. A., and G. R. Crabtree. 1993. Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506. Ann. NY Acad. Sci. 696:20.
55. Klasen, S., F. Pages, J. F. Peyron, D. A. Cantrell, and D. Olive. 1998. Two distinct regions of the CD28 intracytoplasmic domain are involved in the tyrosine phosphorylation of Vav and GTPase activating protein-associated p62 protein. Int. Immunol. 10:481.
56. Karin, M., L. Zg, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240.
57. Tanaka, M., M. E. Fuentes, K. Yamaguchi, M. H. Durnin, S. A. Dalrymple, K. L. Hardy, and D. V. Goeddel. 1999. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10:421.
58. Li, Q., D. Van Antwerp, F. Mercuric, K. F. Lee, and I. M. Verma. 1999. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284:321.
59. Ferreira, V., N. Sidenius, N. Tarantino. P. Hubert, L. Chatenoud, F. Blasi, and M. Korner. 1999. In vivo inhibition of NF-κB in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis. J. Immunol. 162:6442.
60. Ranger, A. M., M. R. Hodge, E. M. Gravallese, M. Oukka, L. Davidson, F W. Alt, F. C. de la Brousse, T. Hoey, M. Grusby, and L. H. Glimcher, 1998. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 8:125.
61. Yoshida, H., H. Nishina, H. Takimoto, L. E. Marengere, A. C. Wakeham, D. Bouchard, Y. Y. Kong, T. Ohteki, A. Shahinian, M. Bachmann, et al. 1998. The transcription factor NF-ATc1 regulates lymphocyte proliferation and Th2 cytokine production. Immunity 8:115.
62. Schraven, B., A. Marie-Cardine, C. Hubener, E. Bruyns, and I. Ding. 1999. Integration of receptor-mediated signals in T cells by transmembrane adaptor proteins. Immunol. Today 20:431.
63. Jackman, J. K., D. G. Motto, Q. Sun, M. Tanemoto, C. W. Turck, G. A. Peltz, G. A. Koretzky, and P. R. Findell. 1995. Molecular cloning of SLP-76, a 76-κDa tyrosine phosphoprotein associated with Grb2 in T cells. J. Biol. Chem. 270: 7029.
64. Yablonski, D., M. R. Kuhne, T. Kadlecek, and A. Weiss. 1998. Uncoupling of nonreceptor tyrosine kinases from PLC-γ1 in an SLP-76-deficient T cell. Science 281:413.
65. Clements, J. L., B. Yang, S. E. Ross Barta, S. L. Eliason, R. F. Hrstka, R. A. Williamson, and G. A. Koretzky. 1998. Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science 281:416.
66. Pivniouk, V., E. Tsitsikov, P. Swinton, G. Rathbun, F. W. Alt, and R. S. Geha. 1998. Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76. Cell 94:229.
67. Fischer, K. D., Y. Y. Kong, H. Nishina, K. Tedford, L. E. Marengere, I. Kozieradzki, T. Sasaki, M. Starr, G. Chan, S. Gardener, et al. 1998. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol. 8:554.
68. Gulbranson Judge, A., V. L. Tybulewicz, A. E. Walters, K. M. Toellner, I. C. MacLennan, and M. Turner. 1999. Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T cell help. Eur. J. Immunol. 29:477.
69. Schroeder, J. T., B. P. Howard, M. K. Jenkens, A. Kagey Sobotka. L. M. Lichtenstein, and D. W. MacGlashan, Jr. 1998. IL-4 secretion and histamine release by human basophils are differentially regulated by protein kinase C activation. J. Leukocyte Biol. 63:692.
70. Meller, N., Y. C. Liu, T. L. Collins, N. Bonnefoy Berard, G. Baier, N. Isakov, and A. Altman. 1996. Direct interaction between protein kinase C θ (PKC θ) and 14-3-3 τ in T cells: 14-3-3 overexpression results in inhibition of PKC θ translocation and function. Mol. Cell Biol. 16:5782.